This company has been marked as potentially delisted and may not be actively trading. Zynerba Pharmaceuticals (ZYNE) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock ZYNE Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period 22q11.2 Deletion Syndrome Market Research Report 2025: Zynerba Pharmaceuticals is at the Forefront with Its Clinical-stage Therapy Zygel (ZYN002)June 25, 2025 | globenewswire.comHarmony Biosciences: If It Ain't BrokeJune 5, 2025 | seekingalpha.comUS Penny Stocks To Watch In October 2024October 28, 2024 | uk.finance.yahoo.comDiscover 3 US Penny Stocks With Market Caps Over $70MOctober 24, 2024 | uk.finance.yahoo.comAtea Pharmaceuticals Leads The Charge In US Penny Stocks SpotlightOctober 22, 2024 | uk.finance.yahoo.comFragile X Syndrome Therapeutic Pipeline Research Report 2024 Featuring Zynerba, Tetra Discovery Partners, Nova Mentis, Neuren Pharmaceuticals, and Tetra Discovery PartnersJuly 31, 2024 | globenewswire.comHarmony Biosciences Reports Strong Third Quarter 2023 Financial ResultsOctober 31, 2023 | finance.yahoo.comWhy Shares of Harmony Bioscience Are Falling on FridayOctober 13, 2023 | fool.comNew Possibilities For Cannabinoid Treatments: Acquisition To Transform Neuropsychiatric Disorder TherapiesOctober 11, 2023 | markets.businessinsider.comHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA PHARMACEUTICALS AND EXPANDS PIPELINEOctober 11, 2023 | finance.yahoo.comZynerba Pharmaceuticals (Nasdaq:ZYNE) HeadlineTrading was temporarily halted for "ZYNE" at 07:10 PM with a stated reason of "News pending."...October 11, 2023 | marketbeat.comImportant Information for Zynerba Pharmaceuticals Stockholders to Tender Shares for the Harmony Transaction: Process and InstructionsOctober 4, 2023 | finance.yahoo.com20 Countries With Highest Rate of EpilepsySeptember 29, 2023 | finance.yahoo.comZynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023September 29, 2023 | finance.yahoo.comHarmony Biosciences extends deadline for Zynerba shareholders on up to $200M dealSeptember 27, 2023 | bizjournals.comZynerba Pharmaceuticals (Nasdaq:ZYNE) HeadlineTrading was temporarily halted for "ZYNE" at 07:09 PM with a stated reason of "News pending."...September 27, 2023 | marketbeat.comInsider Sell: President Terri Sebree Sells 12,401 Shares of Zynerba Pharmaceuticals IncSeptember 14, 2023 | finance.yahoo.comZynerba Pharmaceuticals Presents Positive Data from Phase 2 INSPIRE Trial in 22q11.2 Deletion Syndrome at The Society for the Study of Behavioural Phenotypes (SSBP) 25th International Research SymposiumSeptember 14, 2023 | finance.yahoo.comHC Wainwright & Co. Downgrades Zynerba Pharmaceuticals (ZYNE)August 16, 2023 | msn.comIs Zynerba Pharmaceuticals (NASDAQ:ZYNE) In A Good Position To Deliver On Growth Plans?August 15, 2023 | finance.yahoo.comZynerba Pharmaceuticals Shares Soar on Harmony Biosciences Deal >ZYNEAugust 14, 2023 | marketwatch.comCrude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike HigherAugust 14, 2023 | markets.businessinsider.comZYNE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Zynerba Pharmaceuticals, Inc. Is Fair to ShareholdersAugust 14, 2023 | technews.tmcnet.comHARMONY BIOSCIENCES TO ACQUIRE ZYNERBA PHARMACEUTICALS, INC.August 14, 2023 | finance.yahoo.comZynerba Pharmaceuticals (Nasdaq:ZYNE) HeadlineTrading was temporarily halted for "ZYNE" at 07:08 AM with a stated reason of "News pending."...August 14, 2023 | marketbeat.comZynerba Pharmaceuticals Announces New Date for Reconvened Annual MeetingJuly 25, 2023 | finance.yahoo.comZynerba (ZYNE) Upgraded to Buy: What Does It Mean for the Stock?June 29, 2023 | finance.yahoo.comZynerba Pharmaceuticals Announces Further Adjournment of Annual MeetingJune 28, 2023 | finance.yahoo.comZynerba Pharmaceuticals to Present at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual ConferenceJune 20, 2023 | finance.yahoo.comZynerba Pharmaceuticals Announces Partial Adjournment of Annual MeetingJune 13, 2023 | finance.yahoo.comMain Line CBD drug developer plans reverse stock split to boost share priceMay 17, 2023 | bizjournals.comZynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational HighlightsMay 15, 2023 | finanznachrichten.deZynerba Pharma (ZYNE) Earnings Dates & ReportsMay 15, 2023 | investing.comZynerba Pharmaceuticals R&D Expenses For Q1 Reach $7.1M, Here Are The DetailsMay 15, 2023 | msn.comZynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational HighlightsMay 15, 2023 | finance.yahoo.comZynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational HighlightsMay 15, 2023 | finance.yahoo.comFibromyalgia Treatment Drug Market Overview and Scope By 2030April 18, 2023 | marketwatch.comZynerba Pharmaceuticals Presents Data on Zygel(TM) at the 55th Gatlinburg ConferenceApril 13, 2023 | marketwatch.comZynerba Pharmaceuticals Presents Data on Zygel™ at the 55th Gatlinburg ConferenceApril 12, 2023 | finance.yahoo.comZynerba Pharmaceuticals Announces Poster Presentations at the 55th Gatlinburg ConferenceApril 5, 2023 | finance.yahoo.comZynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational HighlightsMarch 28, 2023 | finanznachrichten.deZynerba Pharmaceuticals R&D Expenses For FY22 Reach $21.1M, What About Net Loss?March 28, 2023 | benzinga.comZynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational HighlightsMarch 28, 2023 | finance.yahoo.comZynerba Pharmaceuticals, Inc.: Zynerba Pharmaceuticals Confirms Not Holding Cash Deposits or Securities at Silicon Valley BankMarch 14, 2023 | finanznachrichten.deZynerba Pharmaceuticals Confirms Not Holding Cash Deposits or Securities at Silicon Valley BankMarch 13, 2023 | finance.yahoo.comAnalysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (BMRN) and Armata Pharmaceuticals (ARMP)March 7, 2023 | markets.businessinsider.comZynerba Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare ConferenceMarch 7, 2023 | finance.yahoo.comZynerba Pharmaceuticals to Present at the Cowen 43rd Annual Health Care ConferenceMarch 1, 2023 | finance.yahoo.comFibromyalgia Treatment Drug Market Outlook 2023 and Forecast to 2028 with Top Countries DataFebruary 21, 2023 | marketwatch.com2023, Pain Management Drugs Market to Experience a Significant Increase in Revenues by 2027February 13, 2023 | marketwatch.com Get Zynerba Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYNE and its competitors with MarketBeat's FREE daily newsletter. Email Address ZYNE Media Mentions By Week ZYNE Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZYNE News Sentiment▼0.000.99▲Average Medical News Sentiment ZYNE News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZYNE Articles This Week▼00▲ZYNE Articles Average Week Get Zynerba Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ZYNE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TSVT News SLRN News CYBN News PROC News OPTN News VIRI News PYRGF News AADI News OSTX News ATNM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZYNE) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn extra $1,000 per month?A little-known Title 15 provision could let you collect instant payouts — $100 to $1,000 — directly from your ...TradeSmith | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zynerba Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Zynerba Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZYNE Stock Alerts